Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
YUAN LU
CONTACT
Lead
Abbisko Therapeutics Co, Ltd
This is a phase II, open-label study to evaluate safety, tolerability, pharmacokinetics (PK), and clinical benefit of Pimicotinib (ABSK021) in combination with chemotherapy with or without Toripalimab in patients with advanced pancreatic cancer.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted